![Philippe van Holle](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Philippe van Holle
Keine laufenden Positionen mehr
Profil
Philippe van Holle is the founder of Amsterdam Molecular Therapeutics (AMT) Holding NV, which was founded in 1998.
He held the title of Member-Supervisory Board from 2010 to 2013.
Mr. van Holle's former jobs include being an Independent Director at Argos Therapeutics, Inc. from 2015 to 2016, and being the President of Celgene International SARL from 2005 to 2014.
He also held the title of Principal at Amgen Europe BV.
Mr. van Holle received an MBA from Cornell University and an undergraduate degree from the University of Antwerp in 1976.
Ehemalige bekannte Positionen von Philippe van Holle
| Unternehmen | Position | Ende |
|---|---|---|
| ARGOS THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 13.12.2016 |
Celgene International SARL
 Celgene International SARL Pharmaceuticals: MajorHealth Technology Operates as bio-pharmaceutical company, which discovers, develops and commercializes therapies for unmet medical needs in cancer | Präsident | 01.10.2014 |
Amsterdam Molecular Therapeutics (AMT) Holding NV
 Amsterdam Molecular Therapeutics (AMT) Holding NV Miscellaneous Commercial ServicesCommercial Services Specializes in human gene therapy for metabolic disorders and ocular diseases | Gründer | 11.03.2013 |
Amgen Europe BV
 Amgen Europe BV Medical DistributorsDistribution Services Wholesales pharmaceutical products | Corporate Officer/Principal | - |
Ausbildung von Philippe van Holle
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
46
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Celgene International SARL
Celgene International SARL Pharmaceuticals: MajorHealth Technology Operates as bio-pharmaceutical company, which discovers, develops and commercializes therapies for unmet medical needs in cancer | Health Technology |
Argos Therapeutics, Inc.
 Argos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes personalized immunotherapies for the treatment of cancer and infectious diseases | Health Technology |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Amsterdam Molecular Therapeutics (AMT) Holding NV
Amsterdam Molecular Therapeutics (AMT) Holding NV Miscellaneous Commercial ServicesCommercial Services Specializes in human gene therapy for metabolic disorders and ocular diseases | Commercial Services |
Amgen Europe BV
Amgen Europe BV Medical DistributorsDistribution Services Wholesales pharmaceutical products | Distribution Services |
University of Antwerp
 University of Antwerp Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Wählen Sie MarketScreener 
